- Home
- WAFU vs EDSA Comparison
WAFU vs EDSA Comparison
Compare WAFU & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WAFU | EDSA |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 7.5M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WAFU | EDSA |
|---|---|---|
| Price | $1.65 | $11.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 9.9K | ★ 1.0M |
| Earning Date | 07-31-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.36 | $0.72 |
| 52 Week High | $2.17 | $20.32 |
Technical Indicators
Market Signals| Indicator | WAFU | EDSA |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 47.73 |
| Support Level | $1.63 | $1.61 |
| Resistance Level | $1.73 | $20.32 |
| Average True Range (ATR) | 0.06 | 2.25 |
| MACD | 0.00 | -0.85 |
| Stochastic Oscillator | 25.00 | 22.23 |
Price Performance
Historical ComparisonAbout WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.